Market Tracker

08/01 9:54am ET

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

4.95
Data as of Jul 31
 0.00 / 0.00%
Today’s Change
4.40
Today|||52-Week Range
8.19
-18.45%
Year-to-Date
No recent news for Nymox Pharmaceutical Corp.

Today’s Trading

Previous close4.95
Today’s openn.a.
Day’s range-- - --
Volume0
Average volume (3 months)66,259
Market cap$173.5M
Dividend yield--
Data as of 07/31/2014

Growth & Valuation

Earnings growth (last year)+39.13%
Earnings growth (this year)0.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+9.32%
P/E ratioNM
Price/Sales61.71
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ATNMActinium Pharmaceuti...+0.14+2.22%
ELTPElite Pharmaceutical...-0.01-1.90%
STMLStemline Therapeutic...-0.07-0.55%
EBIOEleven Biotherapeuti...-1.38-12.58%
Data as of 9:38am ET, 08/01/2014

Financials

Next reporting dateAugust 15, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$3.4M
Annual profit (last year)-$4.9M
Net profit margin-146.13%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer
André Monette
Corporate headquarters
Saint-Laurent, Quebec

Forecasts